Medpace Holdings Inc MEDP

US Life Sciences Tools & Services

$618.88 ▼ -0.28% ($-1.71)

Open $620.60

Prev Close $620.59

Day Range $608.11 – $620.60

52W Range $373.00 – $677.90

Market Cap $17.27B

P/E (TTM) 34.92

Beta 1.13

EPS (TTM) $17.05

📋 Company Profile

Industry	Life Sciences Tools & Services
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2016-08-11
Shares Out.	27,910,000
Website	investor.medpace.com/ ↗
Phone	13026587581
Employees	6,500
Revenue	$707.3M
Gross Profit	$201.6M
Net Income	$121.4M
Free Cash Flow	$706.7M
Total Assets	$2.06B
Total Liabilities	$1.62B
Equity	$433.9M

About Medpace Holdings Inc

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Medpace Holdings Inc is a publicly traded company under the ticker symbol MEDP on the NASDAQ NMS - GLOBAL MARKET, operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.